Based on the strong implication of H. pylori and its oncoprotein CagA in GC as well as in other extra-gastric diseases, it become crucial to eradicate this bacterial infection as a preventive measure toward GC especially in countries where the prevalence of both GC and H. pylori is high. Here, S100A8 is linked to stomach disorder.